GL1X · GenesisL1 explorer

MolNFT v1 · #137025 · protein

Crystal structure of the R515W missense variant of human PGM1

5VBI · Phosphoglucomutase-1: “Crystal structure of the R515W missense variant of human PGM1”. X-ray diffraction, 2 ligands (MG, SO4), 10 pockets (best druggability 0.70). MolNFT v1 #137025 on GenesisL1: 3D structure, binding sites and…

PDB
5VBI
Type
protein
Length
1,125 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphoglucomutase-1
EC
5.4.2.2
UniProt
P36871
Ligands
MG, SO4
Pockets
10 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 37% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphoglucomutase-1 (EC 5.4.2.2)protein56337% helix, 26% strandP36871
BPhosphoglucomutase-1 (EC 5.4.2.2)protein56236% helix, 25% strandP36871

Ligands and binding sites

  • MG · Magnesium ion · metal · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 5 copies · chains A, B
  • GOL · Glycerol · additive · 13 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16720.700.7863GOL
26160.680.7764SO4, GOL
33240.580.7744empty
41240.390.7426GOL
51040.390.7521empty

Interfaces

1 interface between chains.

  • A–B · 270 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 5VBI · Crystal Structure of the R515W missense variant of human PGM1 · the same entry in another collection · chain B against B, TM-score 1.00
  • P36871 · AlphaFold monomer V2.0 prediction for phosphoglucomutase-1 (P36871) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.